BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 27119139)

  • 1. Translating Science into Survival: Report on the Inaugural International Cancer Immunotherapy Conference.
    Hubbard-Lucey VM; Tontonoz MJ
    Cancer Immunol Res; 2016 Jan; 4(1):3-11. PubMed ID: 27119139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Translating Science into Survival: Report on the Second International Cancer Immunotherapy Conference.
    Brodsky AN; Hubbard-Lucey VM
    Cancer Immunol Res; 2016 Dec; 4(12):996-1000. PubMed ID: 27908930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translating Science into Survival: Report on the Fourth International Cancer Immunotherapy Conference.
    Diken M; Ravoori S; Brodsky AN
    Cancer Immunol Res; 2019 Jan; 7(1):2-5. PubMed ID: 30602506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translating Science into Survival: Report on the Third International Cancer Immunotherapy Conference.
    Diken M; Chu KK; Brodsky AN
    Cancer Immunol Res; 2018 Jan; 6(1):10-13. PubMed ID: 29298782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer Immunology and Immunotherapy: Taking a Place in Mainstream Oncology Keystone Symposia Meeting Summary.
    Gubin MM
    Cancer Immunol Res; 2017 Jun; 5(6):434-438. PubMed ID: 28576922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translating Science into Survival: Report on the Fifth International Cancer Immunotherapy Conference.
    Diken M; Kepp O; Brodsky AN
    Cancer Immunol Res; 2020 Jan; 8(1):3-6. PubMed ID: 31909729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translating Science into Survival: Report on the Sixth International Cancer Immunotherapy Conference.
    De Martino M; Pancholi NJ; Brodsky AN
    Cancer Immunol Res; 2023 Feb; 11(2):145-149. PubMed ID: 36734102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translating Science into Survival: Report on the Seventh International Cancer Immunotherapy Conference.
    Beck JD; Kenski J; Perrone M; Pocaterra A; Honey K
    Cancer Immunol Res; 2024 Feb; 12(2):144-148. PubMed ID: 38231158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer immunotherapy out of the gate: the 22nd annual Cancer Research Institute International Immunotherapy Symposium.
    Tontonoz M; Gee CE
    Cancer Immunol Res; 2015 May; 3(5):444-8. PubMed ID: 25941356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 14th European Immunology Meeting--EFIS 2000. 23-27 September 2000, Poznañ, Poland.
    Wysocki PJ; Nawrocki S; Mackiewicz A
    Expert Opin Biol Ther; 2001 Jan; 1(1):135-40. PubMed ID: 11727543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The European Academy of Tumor Immunology: Bridging fields, continents and generations.
    Kroemer G; Fridman WH; Sautès-Fridman C; Zitvogel L
    Oncoimmunology; 2012 Mar; 1(2):127-128. PubMed ID: 22720233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer immunotherapy 2005: Mainz, Germany, 12-13 May 2005.
    Britten CM; Gouttefangeas C; Kreiter S
    Cancer Immunol Immunother; 2006 Apr; 55(4):475-80. PubMed ID: 16193336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of the 25th annual scientific meeting of the International Society for Biological Therapy of Cancer.
    Balwit JM; Kalinski P; Sondak VK; Coulie PG; Jaffee EM; Gajewski TF; Marincola FM
    J Transl Med; 2011 May; 9():60. PubMed ID: 21569425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ninth annual meeting of the Association for Cancer Immunotherapy (CIMT 2011), May 25-27, 2011, Mainz, Germany.
    Hobohm K; Seppmann T; Britten CM; Hoff H
    Cancer Immunol Immunother; 2012 Jan; 61(1):137-43. PubMed ID: 22048716
    [No Abstract]   [Full Text] [Related]  

  • 15. Tumor immunology: multidisciplinary science driving basic and clinical advances.
    Keenan BP; Jaffee EM; Armstrong TD
    Cancer Immunol Res; 2013 Jul; 1(1):16-23. PubMed ID: 24409447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Fourteenth International Conference on Progress in Vaccination Against Cancer (PIVAC-14), September 24-26, 2014, Rome, Italy: rethinking anti-tumor vaccines in a new era of cancer immunotherapy.
    Signori E; Cavallo F
    Cancer Immunol Immunother; 2015 Oct; 64(10):1349-56. PubMed ID: 25762082
    [No Abstract]   [Full Text] [Related]  

  • 17. Report on the sixth annual meeting of the Association for Immunotherapy of Cancer (CIMT), May 15 and 16, 2008 in Mainz, Germany.
    Welters MJ; van Montfoort N; Khan S; Meyer RG; Britten CM
    Cancer Immunol Immunother; 2009 May; 58(5):777-87. PubMed ID: 18982325
    [No Abstract]   [Full Text] [Related]  

  • 18. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CIMT 2014: Next waves in cancer immunotherapy--report on the 12th annual meeting of the Association for Cancer Immunotherapy: May 6–8 2014, Mainz, Germany.
    Diken M; Boegel S; Grunwitz C; Kranz LM; Reuter K; van de Roemer N; Vascotto F; Vormehr M; Kreiter S
    Hum Vaccin Immunother; 2014; 10(10):3090-100. PubMed ID: 25483671
    [No Abstract]   [Full Text] [Related]  

  • 20. Conference scene: Immune signatures in the tumor and beyond.
    Kandalaft LE; Kalos M; Melief CJ; Speiser DE; Coukos G
    Immunotherapy; 2012 Aug; 4(8):761-72. PubMed ID: 22947003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.